Live Breaking News & Updates on Amneal Pharmaceuticals Company Profile

Stay updated with breaking news from Amneal pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $8.25 Consensus Target Price from Analysts

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average rating of “Buy” by the four ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on […] ....

Piper-sandler , News-ratings-for-amneal-pharmaceuticals-daily , Nasdaq , Amneal-pharmaceuticals-company-profile , Goldman-sachs-group , Amneal-pharmaceuticals , Amneal-pharmaceuticals-inc , Amneal-pharmaceuticals-stock-down , Sherbrooke-park-advisers , Atlanta-consulting-group-advisors , Hedge-funds-weigh-in-on-amneal-pharmaceuticals , Get-free-report

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 6.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s stock price shot up 6.4% on Tuesday . The company traded as high as $6.90 and last traded at $6.86. 685,390 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 1,502,379 shares. The stock had previously closed at $6.45. Analysts […] ....

Piper-sandler , Sherbrooke-park-advisers , Barclays , News-ratings-for-amneal-pharmaceuticals-daily , Amneal-pharmaceuticals , Atlanta-consulting-group-advisors , Nasdaq , Amneal-pharmaceuticals-company-profile , Amneal-pharmaceuticals-inc , Amneal-pharmaceuticals-stock-performance , Goldman-sachs-group , Institutional-investors-weigh-in-on-amneal-pharmaceuticals

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $7.31

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $7.31
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler , Amneal-pharmaceuticals , Nasdaq , Amneal-pharmaceuticals-stock-performance , News-ratings-for-amneal-pharmaceuticals-daily , Sherbrooke-park-advisers , Advisory-services , Goldman-sachs-group , Amneal-pharmaceuticals-inc , Barclays , Amneal-pharmaceuticals-company-profile , Institutional-trading-of-amneal-pharmaceuticals

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $5.86 and last traded at $5.84. 420,424 shares were traded during trading, a decline of 72% from the average session volume of 1,499,807 shares. The stock had previously closed at $5.73. Analyst Ratings Changes A […] ....

Piper-sandler , Barclays , Voloridge-investment-management , News-ratings-for-amneal-pharmaceuticals-daily , Barclays-plc , Group-plc , Institutional-investors-weigh-in-on-amneal-pharmaceuticals , Goldman-sachs-group , Amneal-pharmaceuticals , Amneal-pharmaceuticals-inc , Nasdaq , Amneal-pharmaceuticals-company-profile

Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volume

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 454,208 shares changed hands during mid-day trading, a decline of 69% from the previous session’s volume of 1,481,910 shares.The stock last traded at $5.96 and had previously closed at $5.81. Analysts Set New Price Targets Several research firms […] ....

Piper-sandler , Vanguard-group-inc , Blackrock-inc , Nasdaq , Millennium-management , Barclays , Amneal-pharmaceuticals-company-profile , News-ratings-for-amneal-pharmaceuticals-daily , Amneal-pharmaceuticals-stock , Amneal-pharmaceuticals-inc , Morgan-stanley , Goldman-sachs-group